| Don Featherstone, RPH | |
|
1180 Swan Horseshoe Dr, Bigfork, MT 59911-6548 | |
| (520) 668-6135 | |
| Not Available |
| Full Name | Don Featherstone |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1180 Swan Horseshoe Dr, Bigfork, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639774821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7899 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Don Featherstone, RPH 1180 Swan Horseshoe Dr, Bigfork, MT 59911-6548 Ph: (520) 668-6135 | Don Featherstone, RPH 1180 Swan Horseshoe Dr, Bigfork, MT 59911-6548 Ph: (520) 668-6135 |
News Archive
According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA .
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two Johns Hopkins studies.
Long-time healthcare education business owner, Deborah Kann Schwarzberg, has established GlobalHealth Education & Training®, a corporate training and degree-granting educational service. GlobalHealth was formed to respond to the growing demand for trained employees and management within the healthcare and ancillary industries to enhance their formal education and attain advanced degrees online.
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.
› Verified 2 days ago
Sara L Mcdonald, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8111 Mt Highway 35, Bigfork, MT 59911 Phone: 406-837-4370 Fax: 406-837-4390 | |
Kimberly Murray, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8111 Mt Highway 35, Bigfork, MT 59911 Phone: 406-837-4370 Fax: 406-837-4390 | |
Stephanie Mills, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8111 Mt Highway 35 Ste 7, Bigfork, MT 59911 Phone: 406-837-4370 |